Sign in

CIK 0001802255 · Accelerated filer

Guardian Pharmacy Services, Inc.

Sign in to watch
Ticker
GRDN
Exchange
NYSE
Industry
Retail-Drug Stores and Proprietary Stores
FY end
Dec 31
Incorporated
GA
Entity type
operating
EIN
200100834
Phone
(404) 810-0089
Business address
300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA, GA, 30339
Former names
Guardian Pharmacy Services, Inc., Guardian Pharmacy, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-20 Salentine Thomas J Jr Director Sale −3,570,677 $29.68 $106.0M 4,469,316
2026-03-20 Bindley Capital Partners I, LLC 10% owner Sale −3,570,677 $29.68 $106.0M 4,469,316
2026-03-20 Ackerman John Director Sale −827,636 $29.68 $24.6M 1,035,928
2026-03-20 Ackerman John Director Sale −275,728 $29.68 $8.2M 345,123
2026-03-20 BINDLEY WILLIAM E Director Sale −3,570,677 $29.68 $106.0M 4,469,316
2026-03-20 Forbes Kendall See Remarks Sale −346,672 $29.68 $10.3M 453,256
2026-03-20 Cardinal Equity Fund, L.P. Member of 10% owner group Sale −275,728 $29.68 $8.2M 345,123
2026-03-01 Morris David K See Remarks Grant or award +8,952 442,327
2026-03-01 Forbes Kendall See Remarks Grant or award +8,952 799,928
2026-02-11 Forbes Kendall See Remarks Grant or award · Stock Option (right to buy) +50,000 50,000
2026-02-11 Burke Fred See Remarks Grant or award · Stock Option (right to buy) +75,000 75,000
2026-02-11 Morris David K See Remarks Grant or award · Stock Option (right to buy) +50,000 50,000
2025-12-04 Burke Fred See Remarks Gift −200,000 1,511,845
2025-12-04 Forbes Kendall See Remarks Gift −21,500 790,976
2025-12-03 COSLER STEVEN D Director Purchase +3,370 $29.61 $100K 24,984
2025-09-27 Ackerman John Director Option exercise +1,413,940 1,863,564
2025-09-27 Ackerman John Director Option exercise +471,057 620,851
2025-09-27 Ackerman John Director Option exercise · Class B Common Stock −1,413,940 2,827,878
2025-09-27 Ackerman John Director Option exercise · Class B Common Stock −471,057 942,114
2025-09-27 Forbes Kendall See Remarks Option exercise +608,570 812,476

Page 4 of 8 · 149 trades